166 related articles for article (PubMed ID: 22512761)
1. Statins in dermatology: is nonmelanoma skin cancer the dark side of the moon?
Mascitelli L; Goldstein MR
Int J Dermatol; 2013 Jul; 52(7):899-900. PubMed ID: 22512761
[No Abstract] [Full Text] [Related]
2. Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence.
Nardone B; Orrell KA; Vakharia PP; West DP
Expert Opin Drug Saf; 2018 Feb; 17(2):139-147. PubMed ID: 29103328
[TBL] [Abstract][Full Text] [Related]
3. Cancer induction by immunosuppression in psoriasis after heavy PUVA treatment.
Molin L; Larkö O
Acta Derm Venereol; 1997 Sep; 77(5):402. PubMed ID: 9298142
[No Abstract] [Full Text] [Related]
4. Detection and treatment of nonmelanoma skin cancer prevent disfigurement and death.
Cutis; 1999 Jun; 63(6):344. PubMed ID: 10388957
[No Abstract] [Full Text] [Related]
5. Nonmelanoma skin cancer of the head and neck: clinical evaluation and histopathology.
Gencoglan G; Ozdemir F
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):423-35. PubMed ID: 23084295
[TBL] [Abstract][Full Text] [Related]
6. Nonmelanoma skin cancer.
Katz MH
Md Med J; 1997; 46(5):239-42. PubMed ID: 9159053
[TBL] [Abstract][Full Text] [Related]
7. Nonmelanoma skin cancer.
Epstein JH
Compr Ther; 1996 Mar; 22(3):179-82. PubMed ID: 8706389
[No Abstract] [Full Text] [Related]
8. Skin cancer diagnosis: shining light into dark places.
Rees J
Acta Derm Venereol; 2013 May; 93(3):259-60. PubMed ID: 23420414
[No Abstract] [Full Text] [Related]
9. Rheumatoid arthritis, TNF inhibitors, and non-melanoma skin cancer.
Assassi S
BMJ; 2016 Jan; 352():i472. PubMed ID: 26822198
[No Abstract] [Full Text] [Related]
10. [Puva therapy and carcinogenesis].
Thomas P; Pannequin C
Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
[No Abstract] [Full Text] [Related]
11. Delayed treatment and continued growth of nonmelanoma skin cancer.
Alam M; Goldberg LH; Silapunt S; Gardner ES; Strom SS; Rademaker AW; Margolis DJ
J Am Acad Dermatol; 2011 May; 64(5):839-48. PubMed ID: 21055843
[TBL] [Abstract][Full Text] [Related]
12. Statin Use and Skin Cancer Risk: A Prospective Cohort Study.
Al Rahmoun M; Ghiasvand R; Cairat M; Mahamat-Saleh Y; Cervenka I; Severi G; Boutron-Ruault MC; Robsahm TE; Kvaskoff M; Fournier A
J Invest Dermatol; 2022 May; 142(5):1318-1325.e5. PubMed ID: 34695411
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of nonmelanoma skin cancer.
Brodland DG
Clin Dermatol; 1995; 13(6):551-7. PubMed ID: 8882766
[No Abstract] [Full Text] [Related]
14. Arsenic and skin cancer: cocarcinogenicity.
Spoor HJ
Cutis; 1976 Nov; 18(5):631-2. PubMed ID: 1022414
[No Abstract] [Full Text] [Related]
15. Re: Nonmelanoma skin cancer and risk for subsequent malignancy.
Grant WB
J Natl Cancer Inst; 2009 Feb; 101(3):210; author reply 210-1. PubMed ID: 19176462
[No Abstract] [Full Text] [Related]
16. Trends in usage of the terms keratinocyte carcinoma and nonmelanoma skin cancer in the medical literature.
Beatson M; Misitzis A; Lew RA; Weinstock MA
Br J Dermatol; 2019 Dec; 181(6):1308-1309. PubMed ID: 31175660
[No Abstract] [Full Text] [Related]
17. [Arsenic and the risk for cancer].
Zachariae H
Ugeskr Laeger; 1972 Dec; 134(51):2720-1. PubMed ID: 4567610
[No Abstract] [Full Text] [Related]
18. Arsenical intoxication due to pollution.
Degreef H; Roelandts R
Arch Belg Dermatol; 1974; 30(1):35-8. PubMed ID: 4283058
[No Abstract] [Full Text] [Related]
19. In Brief: Hydrochlorothiazide and skin cancer.
Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
[No Abstract] [Full Text] [Related]
20. [Clinical and histological studies on the problem of drug-induced arsenic tumors].
Ehlers G
Z Haut Geschlechtskr; 1968 Sep; 43(18):763-74. PubMed ID: 4886760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
